Scanning the signatures in these genomic assays against the ten features used in our ‘normal’ vs. ‘cancer’ model yielded: two genes in common with Prosigna (FOXA1, MMP11), one gene with OncotypeDX (MMP11), one gene with HER2DX (NEK2), and one gene with Breast Cancer Index (NEK2). This evidence concerns the gene FOXA1 and cancer.